<--- Back to Details
First PageDocument Content
Pharmaceuticals policy / Agencies of the European Union / Clinical pharmacology / Drugs / Drug safety / European Medicines Agency / Heads of Medicines Agencies / Pharmacovigilance / Prescription drug / Adverse effect / European Federation of Pharmaceutical Industries and Associations / Pharmaceutical drug
Pharmaceuticals policy
Agencies of the European Union
Clinical pharmacology
Drugs
Drug safety
European Medicines Agency
Heads of Medicines Agencies
Pharmacovigilance
Prescription drug
Adverse effect
European Federation of Pharmaceutical Industries and Associations
Pharmaceutical drug

AESGP AmsterdamFebruaryConference report

Add to Reading List

Source URL: www.aesgp.eu

Download Document from Source Website

File Size: 3,25 MB

Share Document on Facebook

Similar Documents

Prescription Drug Monitoring Program Facts, Figures, and Trends 2nd Quarter 2017 North Dakota Board of Pharmacy Kathy Zahn, RPh Tech, CPhT, Program Administrator 1906 E. Broadway Ave

DocID: 1vfFG - View Document

COMBATING OPIATE ABUSE ACROSS THE DRUG SUPPLY CHAIN Stronger Regulation of Drug Wholesalers Provides Better Tools to Find and Stop Illegal Distribution of Prescription Drugs in Ohio Ohio has helped lead the way in the na

DocID: 1v9jf - View Document

REQUEST FOR MEDICARE PRESCRIPTION DRUG COVERAGE DETERMINATION This form may be sent to us by mail or fax: Address: Fax Number: Envision Rx Options

DocID: 1v86s - View Document

Substance Use Disorder Treatment and Breast Cancer Imaging Cost-Sharing Rider {Drafting Note: Use this rider for plans that provide large group coverage that does not include prescription drug coverage.} T

DocID: 1v0LJ - View Document

Bill 3824: Prescription drug monitoring program

DocID: 1uVvP - View Document